Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSugar cravings on Wegovy are more common than many people expect, and they don't mean the medicine isn't working. Semaglutide changes how your brain processes hunger and reward signals, but that shift isn't instant or perfectly uniform — sweet cravings can persist, flare, or feel oddly specific even as your appetite for meals falls away. This is a prescription-only medicine, and any concerns about how your body is responding are worth raising with your prescriber, who can help you make sense of what you're experiencing and adjust your care accordingly.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
There's a widely held idea that Wegovy switches off all cravings the moment you inject it. That's not quite right, and letting go of that expectation can make the first weeks feel far less confusing. Semaglutide acts on GLP-1 receptors in the gut and brain, slowing gastric emptying and reducing the intensity of hunger signals. It also appears to dampen the dopamine-driven reward response to food, which is part of why many people find high-calorie foods less compelling over time. But the brain's craving circuitry runs on habit as much as hunger. Patterns built over years (reaching for something sweet mid-afternoon, wanting chocolate after dinner) can persist even when the physical appetite that used to drive them has quietened considerably.
So yes, Wegovy does appear to reduce sugar cravings for many people, particularly at higher doses. Clinical trial participants on semaglutide 2.4mg reported reduced appetite and food preoccupation as well as weight loss, as described in the STEP 1 trial published in the New England Journal of Medicine. But the degree varies between individuals. Some notice a dramatic drop in sweet cravings early on; others find the appetite reduction is mostly for savoury food and large meals, while the pull toward sugar remains. Neither is a sign of treatment failure. If you're also considering whether Wegovy sourced through EU-licensed supply routes is an option worth exploring, that page sets out what's available and how it differs. For more on how the body's response to semaglutide unfolds, the Wegovy treatment overview covers the licensed indication and what to expect through the dose escalation.
Several things can keep sweet cravings going even once treatment is established. First, eating less overall sometimes means eating less protein and fibre, the two nutrients most effective at keeping blood glucose steady between meals. When blood sugar dips, the brain sends a fast, clear signal: sugar, now. This isn't unusual or alarming; it's a well-understood physiological response. The fix is structural rather than willpower-based: protein at breakfast, fibre at lunch, and not leaving a six-hour gap between meals.
Second, the nausea that often comes with dose increases can push people toward plain, easily tolerated foods (crackers, toast, juice) that are relatively high in fast-releasing carbohydrate. This can create a short-term loop where the body expects sweetness as a nausea buffer. It usually resolves as the GI side effects settle, which the NHS semaglutide medicines page notes tends to happen within the first few weeks of a new dose. Third, stress, disrupted sleep and dehydration all independently increase craving intensity. Wegovy doesn't insulate against those triggers. If you're finding that your sugar cravings are worsening rather than easing, our page on why sugar cravings can intensify on semaglutide explores the reasons in detail and is worth reading before your next prescriber check-in. Our broader look at cravings on Wegovy covers the full range of food preoccupations that come up during treatment.
For most people, the answer is yes. The appetite-reducing and reward-dampening effects of semaglutide are dose-dependent, the 0.25mg starting dose is calibrated to let the body adjust tolerability-wise, not to deliver the full therapeutic effect. As the dose steps up toward the 2.4mg maintenance level, the majority of people describe a more noticeable shift in how food (including sweet food) registers. Things they used to crave feel less urgent or less interesting. Some describe sweet foods as tasting differently: overly rich, or simply less rewarding than they once were.
That said, the dose-escalation schedule takes several months to complete. Expecting the craving picture to look the same at week four as at week thirty-two isn't realistic. Keeping a simple food and mood diary during those early months can help identify patterns, whether cravings peak at a particular time of day, after certain meals, or alongside specific emotional states. This kind of tracking is practical information for your prescriber. If you're weighing up how Wegovy's dose pathway compares on cost across the full titration, our Wegovy price comparison page sets out what private treatment typically involves financially. For a fuller picture of how sweet cravings specifically tend to shift on semaglutide, this page on Wegovy and sweet cravings goes deeper into what patients and prescribers observe.
The most reliable approach is building a food environment that doesn't rely on the medicine to do all the work. Protein at every meal is the single most consistent lever, it blunts the post-meal blood sugar drop that triggers sweet cravings an hour or two later. Eggs, fish, Greek yoghurt, legumes and lean meat all work. Soluble fibre (oats, lentils, apples, flaxseed) slows glucose absorption and extends satiety in a way that complements how semaglutide already works on gastric emptying.
Hydration is often underestimated. Mild dehydration mimics hunger signals, and the brain frequently reads thirst as a cue for something sweet. A glass of water before deciding whether a craving is real often resolves it. Timing meals at roughly even intervals avoids the blood sugar valleys that the brain interprets as an emergency requiring immediate glucose. And while specific dietary targets are a conversation for your prescriber or a dietitian, the NHS healthy weight guidance provides a sound general framework for eating alongside weight-management treatment.
If you want to talk through your specific experience, whether the cravings are affecting how you feel about treatment or you're wondering whether the pattern is normal, speaking to our prescribers is a straightforward next step. A named prescriber, not software, reads your consultation, and questions like this are exactly the kind they're there to help with.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.